CD44 has been shown to be involved in tumor growth and metastasis and has also been reported as a cancer stem cell (CSC) marker in head and neck squamous cell cancer (HNSCC) (Chen et al., 2014). This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.